Biomimetic Nanoceramics in Clinical Use: From Materials to Applications
Recent developments in nanostructured materials have led to a shift in focus away from the replacement of tissues and towards regeneration. Nanoceramics with biomimetic properties have great potential in bone regeneration and new synthesis strategies have been developed to obtain materials with improved biocompatibility and multifunctional performance. The aim is to develop fully biocompatible implants, which exhibit biological responses at the nanometric scale in the same way that biogenic materials do. Current man-made implants are not fully biocompatible and always result in a foreign body reaction involving inflammatory response and fibrous encapsulation. Great efforts have, therefore, been made to develop synthetic strategies that tailor implant surfaces at the nanometric scale. The intention is to optimize the interaction at the tissue/implant interface thus improving quality of life for patients with enhanced results and shorter rehabilitation periods. This book deals with 'new bioceramics' for 'new applications'. Current and future applications are considered in terms of chemical composition, structure and properties. It explains the processes that (from the point of view of solid state and sol-gel chemistry) lead to better bone implants and other medical devices. The book is structured to make it useful for students of biomaterials, but also as a reference for specialists interested in specific topics. Didactic figures and schemes make it easy for under-graduates to understand and the extended bibliography is indispensable for researchers. The introductions to each chapter deal with some common fundamental concepts thus allowing the comprehension of each one independently. The first chapter describes biological hard tissues in vertebrates, from the point of view of mineralization processes. Concepts of hard tissue mineralization are employed to explain how nature works and an overview of artificial alternatives is provided. Chapter 2 details several synthesis methodologies used to prepare nano-apatites. The aim is to obtain artificial carbonated calcium deficient nano-apatites that resemble, as closely as possible, natural biological apatites. A review on synthesis methods is collected in the bibliography. Chapter 3 describes, in-depth, the biomimetic processes used to prepare apatites similar to biological ones. It focuses on hard tissue-related biomimetism and deals with nanoceramics obtained as a consequence of biomimetic processes. Valuable information about the most widely used biomimetic solutions and evaluation methods are included. The final chapter provides an overview of the current and potential clinical applications of apatite-like biomimetic nanoceramics, intended as biomaterials for hard tissue repair, therapy and diagnosis.

"1101237090"
Biomimetic Nanoceramics in Clinical Use: From Materials to Applications
Recent developments in nanostructured materials have led to a shift in focus away from the replacement of tissues and towards regeneration. Nanoceramics with biomimetic properties have great potential in bone regeneration and new synthesis strategies have been developed to obtain materials with improved biocompatibility and multifunctional performance. The aim is to develop fully biocompatible implants, which exhibit biological responses at the nanometric scale in the same way that biogenic materials do. Current man-made implants are not fully biocompatible and always result in a foreign body reaction involving inflammatory response and fibrous encapsulation. Great efforts have, therefore, been made to develop synthetic strategies that tailor implant surfaces at the nanometric scale. The intention is to optimize the interaction at the tissue/implant interface thus improving quality of life for patients with enhanced results and shorter rehabilitation periods. This book deals with 'new bioceramics' for 'new applications'. Current and future applications are considered in terms of chemical composition, structure and properties. It explains the processes that (from the point of view of solid state and sol-gel chemistry) lead to better bone implants and other medical devices. The book is structured to make it useful for students of biomaterials, but also as a reference for specialists interested in specific topics. Didactic figures and schemes make it easy for under-graduates to understand and the extended bibliography is indispensable for researchers. The introductions to each chapter deal with some common fundamental concepts thus allowing the comprehension of each one independently. The first chapter describes biological hard tissues in vertebrates, from the point of view of mineralization processes. Concepts of hard tissue mineralization are employed to explain how nature works and an overview of artificial alternatives is provided. Chapter 2 details several synthesis methodologies used to prepare nano-apatites. The aim is to obtain artificial carbonated calcium deficient nano-apatites that resemble, as closely as possible, natural biological apatites. A review on synthesis methods is collected in the bibliography. Chapter 3 describes, in-depth, the biomimetic processes used to prepare apatites similar to biological ones. It focuses on hard tissue-related biomimetism and deals with nanoceramics obtained as a consequence of biomimetic processes. Valuable information about the most widely used biomimetic solutions and evaluation methods are included. The final chapter provides an overview of the current and potential clinical applications of apatite-like biomimetic nanoceramics, intended as biomaterials for hard tissue repair, therapy and diagnosis.

171.0 In Stock
Biomimetic Nanoceramics in Clinical Use: From Materials to Applications

Biomimetic Nanoceramics in Clinical Use: From Materials to Applications

Biomimetic Nanoceramics in Clinical Use: From Materials to Applications

Biomimetic Nanoceramics in Clinical Use: From Materials to Applications

Hardcover

$171.00 
  • SHIP THIS ITEM
    Qualifies for Free Shipping
  • PICK UP IN STORE
    Check Availability at Nearby Stores

Related collections and offers


Overview

Recent developments in nanostructured materials have led to a shift in focus away from the replacement of tissues and towards regeneration. Nanoceramics with biomimetic properties have great potential in bone regeneration and new synthesis strategies have been developed to obtain materials with improved biocompatibility and multifunctional performance. The aim is to develop fully biocompatible implants, which exhibit biological responses at the nanometric scale in the same way that biogenic materials do. Current man-made implants are not fully biocompatible and always result in a foreign body reaction involving inflammatory response and fibrous encapsulation. Great efforts have, therefore, been made to develop synthetic strategies that tailor implant surfaces at the nanometric scale. The intention is to optimize the interaction at the tissue/implant interface thus improving quality of life for patients with enhanced results and shorter rehabilitation periods. This book deals with 'new bioceramics' for 'new applications'. Current and future applications are considered in terms of chemical composition, structure and properties. It explains the processes that (from the point of view of solid state and sol-gel chemistry) lead to better bone implants and other medical devices. The book is structured to make it useful for students of biomaterials, but also as a reference for specialists interested in specific topics. Didactic figures and schemes make it easy for under-graduates to understand and the extended bibliography is indispensable for researchers. The introductions to each chapter deal with some common fundamental concepts thus allowing the comprehension of each one independently. The first chapter describes biological hard tissues in vertebrates, from the point of view of mineralization processes. Concepts of hard tissue mineralization are employed to explain how nature works and an overview of artificial alternatives is provided. Chapter 2 details several synthesis methodologies used to prepare nano-apatites. The aim is to obtain artificial carbonated calcium deficient nano-apatites that resemble, as closely as possible, natural biological apatites. A review on synthesis methods is collected in the bibliography. Chapter 3 describes, in-depth, the biomimetic processes used to prepare apatites similar to biological ones. It focuses on hard tissue-related biomimetism and deals with nanoceramics obtained as a consequence of biomimetic processes. Valuable information about the most widely used biomimetic solutions and evaluation methods are included. The final chapter provides an overview of the current and potential clinical applications of apatite-like biomimetic nanoceramics, intended as biomaterials for hard tissue repair, therapy and diagnosis.


Product Details

ISBN-13: 9780854041428
Publisher: RSC
Publication date: 09/17/2008
Series: Nanoscience & Nanotechnology Series , #5
Pages: 192
Product dimensions: 6.30(w) x 9.30(h) x 0.70(d)

About the Author

María Vallet-Regí studied Chemistry at the Universidad Complutense de Madrid (UCM) and received her PhD at the same Universityin 1974. She is Professor of Inorganic Chemistry and Head of the Department of Inorganic and Bioinorganic Chemistry at the Faculty of Pharmacy (UCM). Her current research field is solid state chemistry, covering aspects of synthesis, characterisation and reactivity in oxides and bioceramics. Daniel Arcos completed his PhD on the synthesis and evaluation of bioactive glasses and glass-ceramics in 2002. He has worked previously on structural studies of silicon containing hydroxyapatites. Currently, his research is focused on nanostructured materials for biomedical applications.

Read an Excerpt

Biomimetic Nanoceramics in Clinical Use

From Materials to Applications


By María Vallet-Regí, Daniel Arcos

The Royal Society of Chemistry

Copyright © 2008 María Vallet-Regí and Daniel Arcos
All rights reserved.
ISBN: 978-0-85404-142-8



CHAPTER 1

Biological Apatites in Bone and Teeth


1.1 Hard-Tissue Biomineralisation: How Nature Works

The bones and teeth of all vertebrates are natural composite materials (Figure 1.1), where one of the components is an inorganic nanocrystalline solid with apatite structure and the chemical composition of a carbonated, basic calcium phosphate, hence it can be termed a carbonate-hydroxy-apatite. It amounts to 65% of the total bone mass, with the remaining mass formed by organic matter and water.

Most of the biominerals are inorganic/organic composite materials. In this sense, the bones of vertebrates are also formed by the combination of an inorganic calcium phase – carbonate-hydroxyl-apatite – and an organic matrix.The benefits that the inorganic part brings to this combination are toughness and the ability to withstand pressure.

On the other hand, the organic matrix formed by collagen fibres, glyco-proteins and mucopolysaccharides, provides elasticity and resistance to stress, bending and fracture. Such symbiosis of two very different compounds, with markedly different properties, confers to the final product, i.e. the biomineral, some properties that would be unattainable for each of its individual components per se. This is a fine example in Nature of the advantages that a composite material can exhibit, in order to reach new properties with added value. In fact due to this evidence, a large portion of the modern materials science field is currently focused on the development of composite materials.


1.1.1 Bone Formation

The bone exhibits some physical and mechanical properties that are rather unusual. It is able to bear heavy loads, to withstand large forces and to flex without fracture within certain limits. Besides, the bone also acts as an ion buffer both for cations and anions. From the material point of view, the bone could be simplified as a three-phase material formed by organic fibres, an inorganic nanocrystalline phase, and a bone matrix. Its unique physical and mechanical properties are the direct consequence of intrinsic atomic and molecular interactions within this very particular natural composite material.

Bone is not uniformly dense. It has a hierarchical structure. Due to its true organic-inorganic composite nature, it is able to adopt different structural arrangements with singular architectures, determined by the properties required from it depending on its specific location in the skeleton. Generally speaking, most bones exhibit a relatively dense outer layer, known as cortical or compact bone, which surrounds a less dense and porous, termed trabecular or spongy bone, which is in turn filled with a jelly tissue: the bone marrow. This complex tissue is the body deposit of nondifferentiated trunk cells, precursors of most repairing and regenerating cells produced after formation of the embryonic subject. The bone fulfils critical functions in terms of a structural material and an ion reservoir. Both functions strongly depend on the size, shape, chemical composition and crystalline structure of the mineral phase, and also on the mineral distribution within the organic matrix.

The main constituents of bone are: water; a mineral phase, calcium phosphate in the form of carbonated apatite with low crystallinity and nanometric dimensions, which accounts for roughly two thirds of the bone's dry weight; and an organic fraction, formed of several proteins, among which type-I collagen is the main component, which represents approximately the remaining one third of bone dry weight. The other intervening proteins, such as proteoglicans and glycoproteins, total more than two hundred different proteins, known as noncollagen proteins; their total contribution to the organic constituent, however, falls below 10% of the said organic fraction. These bone constituents are hierarchically arranged with, at least, five levels of organisation. At the molecular level, the polarised triple helix of tropocollagen molecules are grouped in microfibres, with small cavities between their edges, where small apatite crystals – approximately 5 nm × 30 nm sized – nucleate and grow. These microfibres unite to form larger fibres that constitute the microscopic units of bone tissue. Then, these fibres are arranged according to different structural distributions to form the full bone.

It was traditionally believed that the inorganic phase was mainly amorphous calcium phosphate that, in the ageing process, evolved towards nanocrystalline hydroxyapatite. Results of solid-state 31P NMR spectroscopy, however, showed that the amorphous phase is never present in large amounts during the bone development process. Besides, this technique did detect acid phosphate groups. Phosphate functions correspond to proteins with O-phosphoserine and O-phosphotreonine groups, which are probably used to link the inorganic mineral component and the organic matrix. Phosphoproteins are arranged in the collagen fibres so that Ca2+ can be bonded at regular intervals, in agreement with the inorganic crystal structure, hence providing a repeating condition that leads to an ordered sequence of the same unit, i.e. the crystallinity of the inorganic phase. The cells responsible for most of the assembling process are termed osteoblasts. When the main assembling process is completed, the osteoblasts keep differentiating in order to form osteocytes, which are responsible for the bone maintenance process. The controlled nucleation and growth of the mineral take place at the microscopic voids formed in the collagen matrix. The type-I collagen molecules, segregated by the osteoblasts, are grouped in microfibres with a specific tertiary structure, exhibiting a periodicity of 67 nm and 40 nm cavities or orifices between the edges of the molecules. These orifices constitute microscopic environments with free Ca2+ and PO3-4 ions, as well as groups of side chains eligible for bonding, with a molecular periodicity that allows the nucleation of the mineral phase in a heterogeneous fashion. Ca2+ ions deposited and stored in the skeleton are constantly renewed with dissolved calcium ions. The bone growth process can only be produced under a relative excess of Ca2+ and its corresponding anions, such as phosphates and carbonates, at the bone matrix. This situation is achieved due to the action of efficient ATP-powered ionic pumps, such as Ca2+ ATPases for active transportation of calcium. In terms of physiology, carbonate and phosphate are present in the form of HCO-3, HPO2-4 and H2PO-4 anions. When incorporated to the bone, the released protons can move throughout the bone tissue and leave the nucleation and mineralisation area. The nucleation of thin, platelet-shaped apatite crystals, takes place at the bone within discrete spaces inside the collagen fibres, hence restricting a potential primary growth of these mineral crystals, and imposing their discrete and discontinuous quality (Figure 1.2).

Calcium phosphate nanocrystals in bone, formed at the mentioned spaces left between the collagen fibres, exhibit the particular feature of being mono-dispersed and nanometre-sized platelets of carbonate-hydroxyl-apatite. There is no other mineral phase present, and the crystallographic axis c of these crystals is arranged parallel to the collagen fibres and to the largest dimension of the platelet. In the mineral world, the thermodynamically stable form of calcium phosphate under standard conditions is the hydroxyapatite (HA). Generally speaking, this phase grows in needle-like forms, with the c-axis parallel to the needle axis. Figure 1.3 shows the crystalline structure of hydroxyapatite, Ca10(PO4)6(OH)2, which belongs to the hexagonal system, space group P63/m and lattice parameters a = 9.423 Å and c = 6.875 Å.

Besides the main ions Ca2+, PO3-4 and OH-, thecomposition of biological apatites always includes CO2-3 at approximately 4.5%, and also a series of minority ions, usually including Mg2+, Na+, K+, Cl-, F-. These substitutions modify the lattice parameters of the structure as a consequence of the different size of the substituting ions, as depicted in Figure 1.3. This is an important difference between minerals grown in an inorganic or biological environment.

The continuous formation of bone tissue is performed at a peripheral region, formed by an external crust and an internal layer with connective tissue and osteoblast cells. These osteoblasts are phosphate-rich and exude a jelly-like substance, the osteoid. Due to the gradual deposit of inorganic material, this osteoid becomes stiffer and the osteoblasts are finally confined and transformed in bone cells, the osteocytes. The bone-transformation mechanism, and the ability to avoid an excessive bone growth, are both catered for by certain degradation processes that are performed simultaneously to the bone formation. The osteoclasts, which are giant multinucleated cells, are able to catabolyse the bone purportedly using citrates as chelating agent. The control of the osteoclast activity is verified through the action of the parathyroid hormone, a driver for demineralisation, and its antagonist, tireocalcitonin.

The collagen distribution with the orifices previously described is necessary for the controlled nucleation and growth of the mineral, but it might not suffice. There are conceptual postulations of various additional organic components, such as the phosphoproteins, as an integral part of the nucleation core and hence directly involved in the nucleation mechanism. Several immuno-cyto-chemical studies of bone, using techniques such as optical microscopy and high-resolution electron microscopy, have clearly shown that the phosphoproteins are restricted or, at least, largely concentrated at the initial mineralisation location, intimately related to the collagen fibres. It seems that the phosphoproteins are enzymatically phosphored previously to the mineralisation.

The crystallisation of the complex and hardly soluble apatite structures evolves favourably through the kinetically controlled formation of metastable intermediate products. Under in vitro conditions, amorphous calcium phosphate is transformed into octacalcium phosphate (OCP) that, in turn, evolves to carbonate hydroxyapatite; at lower pH values, the intermediate phase seems to be dehydrated dicalcium phosphate (DCPD).

The mechanisms of bone formation are highly regulated processes, which seem to verify the following statements:

- Mineralisation is restricted to those specific locations where crystals are constrained in size by a compartmental strategy.

- The mineral formed exhibits specific chemical composition, crystalline structure, crystallographic orientation and shape. The chemical phase obtained is controlled during the stages of bone formation. In vertebrates, said chemical phase is a hydroxyl-carbonate-apatite, even though the thermodynamically stable form of calciumphosphate in the world of minerals, under standard conditions, is hydroxyapatite.

- Since the mineral deposits onto a biodegradable organic support, complex macroscopic forms are generated with pores and cavities. The assembling and remodelling of the structure are achieved by cell activity, which builds or erodes the structure layer by layer.


Without a careful integration of the whole process, bone formation would be an impossible task. The slightest planning mistake by the body, for instance in its genetic coding or cell messengers, is enough to provoke building errors that would weaken the osseous structure.

The hard tissues in vertebrates are bones and teeth. The differences between them reside in the amounts and types of organic phases present, the water content, the size and shape of the inorganic phase nanocrystals and the concentration of minor elements present in the inorganic phase, such as CO32-, Mg2+, Na+, etc. The definitive set of teeth in higher-order vertebrates has an outer shell of dental enamel that, in an adult subject, does not contain any living cells. Up to 90% of said enamel can be inorganic material, mainly carbonate-hydroxyl-apatite. Enamel is the material that undergoes more changes during the tooth development process. At the initial stage, it is deposited with a mineral content of only 10–20%, with the remaining 80–90% of proteins and special matrix fluids. In the subsequent development stages, the organic components of the enamel are almost fully replaced by inorganic material. The special features of dental enamel when compared with bone material are its much larger crystal domains, with prismatic shapes and strongly oriented, made of carbonate-hydroxyl-apatite (Figure 1.4). There is no biological material that could be compared to enamel in terms of hardness and long life. However, it cannot be regenerated.

The bones, the body-supporting scaffold, can exhibit different types of integration between organic and inorganic materials, leading to significant variations in their mechanic properties. The ratio of both components reflects the compromise between toughness (high inorganic content) and resiliency or fracture strength (low inorganic content). All attempts to synthesise bone replacement materials for clinical applications featuring physiological tolerance, biocompatibility and long-term stability have, up to now, had only relative success; which shows the superiority and complexity of the natural structure where, for instance, a human femur can withstand loads of up to 1650 kg.

The bones of vertebrates, as opposed to the shells of molluscs, can be considered as "living biominerals" since there are cells inside them under permanent activity. It also constitutes a storage and hauling mechanism for two essential elements, phosphorus and calcium, which are mainly stored in the bones. Most of what has been described up to this point, regarding the nature of bone tissue, could be summed up by stating that the bone is a highly structured porous matrix, made of nanocrystalline and nonstoichiometric apatite, calcium deficient and carbonated, intertwined with collagen fibres and blood vessels.

Bone functions are controlled by a series of hormones and bone-growth factors. Figure 1.5 attempts to depict these phenomena in a projection from our macroscale point of view, to the "invisible" nanoscale.

Bone's rigidity, resistance and toughness are directly related to its mineral content. Although resistance and rigidity increase linearly with the mineral content, toughness does not exhibit the same trend, hence there is an optimum mineral concentration that leads to a maximum in bone toughness. This tendency is clearly the reason why the bone exhibits a restricted amount of mineral within the organic matrix. But there are other issues affecting the mechanical properties of bone, derived from the microstructural arrangement of its components. In this sense, the three main components of bone exhibit radically different properties. From this point of view, the biomineral is clearly a composite. The organic scaffold exhibits a fibrous structure with three levels: the individual triple helix molecules, the small fibrils, and its fibre-forming aggregates. These fibres can be packed in many different ways; they host the platelet-shaped hydroxyl-carbonate-apatite crystals. In this sense, the bone could be described as a composite reinforced with platelets, but the order-disorder balance determines the microstructure and, as a consequence, the mechanical properties of each bone. In fact, bones from different parts of the body show different arrangements, depending on their specific purpose.

Bone crystals are extremely small, with an average length of 50 nm (in the 20–150 nm range), 25 nm in average width (10–80 nm range) and thickness of just 2–5 nm. As a remarkable consequence, a large part of each crystal is surface; hence their ability to interact with the environment is outstanding.

Apatite phase contains between 4 and 8% by weight of carbonate, properly described as dahllite. Mineral composition varies with age and it is always calcium deficient, with phosphate and carbonate ions in the crystal lattice. The formula Ca8.3(PO4)4.3(CO)3x(HPO4)y(OH)0. 3 represents the average composition of bone, where y decreases and x increases with age, while the sum x + y remains constant and equal to 1.7. Mineral crystals grow under a specific orientation, with the c-axes of the crystals approximately parallel to the long axes of the collagen fibres where they are deposited. Electron microscopy techniques were used to obtain this information.

The bones are characterised by their composition, crystalline structure, morphology, particle size and orientation. The apatite structure hosts carbonate in two positions: the OH- sublattice producing so-called type A carbonate apatites or the [PO4]- sublattice (type B apatites) (Figure 1.6).

The small apatite crystal size is a very important factor related to the solubility of biological apatites when compared with mineral apatites. Small dimensions and low crystallinity are two distinct features of biological apatites that, combined with their nonstoichiometric composition, inner crystalline disorder and presence of carbonate ions in the crystal lattice, allow their special behaviour to be explained.

Apatite structure allows for wide compositional variations, with the ability to accept many different ions in its three sublattices (Figure 1.7).


(Continues...)

Excerpted from Biomimetic Nanoceramics in Clinical Use by María Vallet-Regí, Daniel Arcos. Copyright © 2008 María Vallet-Regí and Daniel Arcos. Excerpted by permission of The Royal Society of Chemistry.
All rights reserved. No part of this excerpt may be reproduced or reprinted without permission in writing from the publisher.
Excerpts are provided by Dial-A-Book Inc. solely for the personal use of visitors to this web site.

Table of Contents

Chapter 1. Biological apatites in bone and teeth;
Chapter 2 Synthetic nanoapatites;
Chapter 3 Biomimetic nanoapatites on bioceramics;
Chapter 4 Clinical applications of apatite derived nanoceramics;

From the B&N Reads Blog

Customer Reviews